In recent years, the Chk2 protein (which regulates the DDR process) has attracted widespread attention from scholars because it is thought to trigger mitotic catastrophe and thus promote cell death, suggesting it is a promising target for cancer therapy. The gene discussed is CHEK2; the disease is cancer.